These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7779975

  • 1. [Structure and biological properties of a conjugate of Bowman-Birk type soy proteinase inhibitor with a block copolymer of ethylene oxide and propylene oxide].
    Gladysheva IP, Polekhina OV, Shen WC, Shevchenko AA, Kazanskaia NF, Larionova NI.
    Biokhimiia; 1995 Apr; 60(4):523-32. PubMed ID: 7779975
    [Abstract] [Full Text] [Related]

  • 2. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide].
    Larionova NI, Gladysheva IP, Topchieva IN, Kazanskaia NF.
    Biokhimiia; 1993 Oct; 58(10):1658-64. PubMed ID: 8268307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Oct; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
    Ascenzi P, Amiconi G, Bolognesi M, Menegatti E, Guarneri M.
    J Mol Recognit; 1990 Oct; 3(5-6):192-6. PubMed ID: 2096886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR, Fritz H, Auerswald EA, Mentele R, Sampaio M, Sampaio CA, Oliva ML.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):838-43. PubMed ID: 10441512
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
    McBride JD, Watson EM, Brauer AB, Jaulent AM, Leatherbarrow RJ.
    Biopolymers; 2002 Aug 11; 66(2):79-92. PubMed ID: 12325158
    [Abstract] [Full Text] [Related]

  • 18. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
    McBride JD, Brauer AB, Nievo M, Leatherbarrow RJ.
    J Mol Biol; 1998 Sep 18; 282(2):447-58. PubMed ID: 9735299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.